Navigation Links
Krishagni Enables University of New South Wales (Australia) to Adopt caTissue Plus
Date:1/17/2013

(PRWEB) January 17, 2013

Krishagni Solutions today announces collaboration with Translational Cancer Research Network (TCRN) of the University of New South Wales (UNSW), Sydney, Australia to adopt the caTissue Plus Application.

caTissue is a biospecimen management tool developed as part of the caBIG® program, a National Cancer Institute (NCI) initiative. caTissue accelerates research discoveries and improves patient outcomes by linking researchers, physicians, and patients throughout the cancer community. caTissue Plus is an Open Source initiative of Krishagni Solutions to enhance NCI’s version of caTissue with new features, usability and performance enhancements.

In addition to providing support to the TCRN for the adoption of caTissue Plus, Krishagni will also provide ongoing SLA based support for next three years; integrate caTissue Plus with their pathology information system, digital pathology imaging information system, and data migration of two legacy databases. “Krishagni is an integral to the deployment of caTissue Plus at TCRN. Krishagni’s intimate knowledge of caTissue and biobanking domain makes them most suited," said Information Manager, Translational Cancer Research Network UNSW.

Krishagni is an offshore software product development and services company focused on informatics for clinical research based in India. “Many members of our team have been involved in the development of caTissue since 2005. Our team has intimate knowledge of the caTissue product and its technology is based on our active involvement in providing support on the NCI Forums to the caTissue community," said Mr Srikanth Adiga, CEO and Founder of Krishagni. "The first version of caTissue Plus has been adopted in Washington University and is under evaluation in other centres. The adoption at UNSW further confirms the need for such an initiative. We will continue to invest in caTissue with Plus v2.0 being available in Nov/2012 and Plus v3.0 scheduled to be released in early 2013."

For more information on caTissue Services at Krishagni, visit: http://www.catissueplus.org.

About Krishagni:
Krishagni is a software product development and services company with sole focus on Informatics Clinical Research. Our focus on open source based solutions and vast experience in working with academic institutes for past 10+ years, makes us an ideal partner for Clinical Informatics development needs. Our expertise includes web and mobile application development, data warehousing and mining, natural language processing, ETL, system integration (HL7, web services, ESB), and so forth. Our current clients include Washington University, Johns Hopkins, University of Leicester, BRISSKit (U.K.), University of New South Wales, and Univ of Utah.

About TCRN, UNSW:

The TCRN – a translational cancer research program funded by the Cancer Institute NSW – comprises the founding institutions of the University of New South Wales, Prince of Wales Hospital, comprehensive cancer centres at St George and Sutherland hospitals, cancer services at the Royal Hospital for Women, Border Medical Oncology Research Unit, and the University of Technology, Sydney. Biobanking is one of our major initiatives and a core component of this has been establishing the TCRN’s biobank, which is known HSA Biobank, hosted by the Lowy Biorepository at UNSW. One of the aims of HSA Biobank is to provide a streamlined process for the universal collection of biospecimens with linked clinical data from consenting cancer patients undergoing treatment and diagnosis.

For more information, visit: http://www.tcrn.unsw.edu.au , http://www.biorepository.unsw.edu.au

Read the full story at http://www.prweb.com/releases/krishagni/catissue/prweb10220913.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Powerful AAC Device With Intel® i7 Processor Enables Natural Communication for Stroke, ALS and Autism Patients
2. Magnetic actuation enables nanoscale thermal analysis
3. New portable device enables RNA detection from ultra-small sample in only 20 minutes
4. Arizona State University engineers aim to improve performance of technology in extreme environments
5. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
6. Causes of Gulf War Illness are complex and vary by deployment area -- Baylor University study
7. HistoRx Licenses Melanoma Assay from Yale University
8. Epitomics, Inc. and University of California, Davis, Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions
9. Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University
10. Research at Rice University leads to nanotube-based device for communication, security, sensing
11. EUR 1.0 Million Grant Awarded to Exosome Diagnostics and Ludwig Maximilian University from German Federal Ministry for Education and Research to Develop Biofluid-Derived Exosome Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. ... Regeneron Genetics Center (RGC), U.K. Biobank and GSK to generate ... U.K. Biobank resource. The initiative will enable researchers to gain ... medicines for a wide range of serious and life threatening ... ...
(Date:3/22/2017)... JERUSALEM , March 22, 2017 ... ( www.oramed.com ), ... of oral drug delivery systems, announced today that ... Officer, will deliver a presentation titled, "Oral Insulin ... upcoming Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical ... cancer therapeutics designed to target cancer stemness pathways, today ... S. Andrews as Chief Executive Officer, effective April ... Chiang J. Li , M.D., FACP, who has ... years ago. Under his leadership, Boston Biomedical has grown ...
Breaking Biology Technology:
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial ... ...
(Date:3/7/2017)... -- Brandwatch , the leading social intelligence company, today announces ... to uncover insights to support its reporting, help direct future campaigns, ... leading youth charity will be using Brandwatch Analytics social listening and ... understanding of the topics and issues that are a priority for ... "Until ...
(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
Breaking Biology News(10 mins):